Renalytix AI and AstraZeneca team up to improve chronic kidney disease outcomes

Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.
Source: mobihealthnews - Category: Information Technology Source Type: news